Literature DB >> 56779

Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas.

A Arimura, H Sato, A Dupont, N Nishi, A V Schally.   

Abstract

Growth hormone release-inhibiting hormone (somatostatin), a hypothalamic peptide that inhibits the release of growth hormone and also the secretion of insulin glucagon, and gastrin, was found in the rat stomach and pancreas in a concentration similar to that in the hypothalamus, as measured by radioimmunoassay. Somatostatin was also found in the duodenum and jejunum, but in a smaller concentration. Gel filtration of the extracts of the pancreas and stomach on Sephadex G-25 yielded two immunoreactive peaks, one corresponding in each case to the somatostatin tetradecapeptide. The hormone was not detected in other viscera or the ovaries. The results imply that somatostatin may be synthesized in the pancreas and the stomach in addition to the brain, and may be involved in local regulatory mechanisms for pancreatic and gastric secretion as well as secretion of growth hormone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 56779     DOI: 10.1126/science.56779

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  87 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

2.  A Strong Stomach for Somatostatin.

Authors:  Bharath K Mani; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2015-11       Impact factor: 4.736

Review 3.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

4.  Pancreatic immunoreactive somatostatin release.

Authors:  G S Patton; E Ipp; R E Dobbs; L Orci; W Vale; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

5.  Immunohistochemical localization of neurotensin in endocrine cells of the gut.

Authors:  F Sundler; R Håkanson; R A Hammer; J Alumets; R Carraway; S E Leeman; E A Zimmerman
Journal:  Cell Tissue Res       Date:  1977-03-16       Impact factor: 5.249

6.  Sequence of a cDNA encoding pancreatic preprosomatostatin-22.

Authors:  M Magazin; C D Minth; C L Funckes; R Deschenes; M A Tavianini; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Further evidence for an argyrophilic fourth cell type in the pancreatic islet of the rat.

Authors:  M R Schweisthal; J L Shevell; L D Clark
Journal:  Acta Diabetol Lat       Date:  1981 Jul-Sep

8.  Gastrointestinal secretory, motor, circulatory, and metabolic effects of prosomatostatin.

Authors:  S J Konturek; J Tasler; J Jaworek; W Pawlik; K M Walus; V Schusdziarra; C A Meyers; D H Coy; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.

Authors:  J M Conlon; C B Srikant; E Ipp; V Schusdziarra; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Effect of intravenous infusion of somatostatin on gastric, pancreatic and biliary secretion in the rat.

Authors:  M Moriga; K Kojima; M Aono; H Uchino; H Yajima
Journal:  Gastroenterol Jpn       Date:  1978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.